Description
Ondero Met 2.5mg/850mg Tablet
: Usage and Insight
Medicine | Ondero Met 2.5mg/850mg Tablet |
Marketed By | Lupin Ltd. |
Active Ingredient | Metformin 850mg and Linagliptin 2.5mg |
Storage | Store below 30°C |
Consume Type | Oral |
Ondero Met 2.5mg/850mg Tablet – Introduction
Ondero Met 2.5mg/850mg Tablet is a medication containing two active ingredients: lignagliptin and Metformin. These components are present in doses of 2.5mg and 850mg, respectively. The medication is specifically designed to help manage and regulate blood sugar levels in individuals who have been diagnosed with Type-2 diabetes mellitus.This medicine helps to avoid serious issues like kidney damage, loss of vision, heart attack, or stroke.
How Ondero Met 2.5mg/850mg Tablet Works: A Closer Look
Ondero Met 2.5/850 medication combines two drugs, Linagliptin 2.5 mg-Metformin 850 mg, to manage blood sugar levels in people with type 2 diabetes. Metformin works by targeting the liver and muscles. It decreases the amount of sugar the liver produces and makes muscle cells more receptive to insulin, allowing them to absorb sugar from the bloodstream more effectively.
Linagliptin works differently. It inhibits an enzyme called DPP-4, which in turn increases levels of incretin hormones. These hormones have a two-fold effect: they stimulate the pancreas to release more insulin and suppress the release of glucagon, a hormone that raises blood sugar. By working together, these medications help regulate blood sugar levels.
Use
In managing Type 2 Diabetes Mellitus in adults (Best results when used alongside a healthy diet and regular exercise)
Ondero Met 2.5mg/850mg Tablet – The Benefits
Ondero Met 2.5/850 helps maintain optimal blood sugar levels and control blood glucose. This medication also decreases the likelihood of kidney damage, eye complications, nerve problems, and limb loss linked to diabetes.
Ondero Met 2.5mg/850mg Tablet – A Usage Guide
- Usually, one tablet is taken orally once daily. Your doctor may adjust linagliptin metformin dosage based on your response to treatment, up to a maximum dose of 5 mg Linagliptin and 2000 mg Metformin per day.
- Remember to take Ondero Met with food to avoid stomach discomfort, and try to take it at the same time every day to maintain a consistent level of the medicine in your body.
- Do not skip doses or discontinue treatment without consulting your doctor, as it may affect your blood sugar levels.
- The tablet should be swallowed whole with a glass of water. Consuming it after your meal is necessary, specifically after the day’s first meal.
- It should not be crushed, chewed, or broken, as it is an extended-release formulation, and altering its form may affect the controlled release of the medication.
Ondero Met 2.5mg/850mg Tablet – Side Effects
Most adverse effects disappear when your body gets used to the medication and doesn’t require medical attention. See your physician if they continue or if you have concerns about them.
Common Side Effects:
- Nausea: Feeling queasy or an urge to vomit.
- Headache: Mild to moderate head discomfort.
- Hypoglycemia: Monitor your blood sugar levels regularly.
- Tremors: Shaking or trembling of the hands or other body parts.
- Dizziness: Feeling lightheaded or unsteady.
- Weight Gain: Some individuals may experience weight changes
Less Common Side Effects:
- Anxiety
- Blurred Vision
- Chills
- Cold Sweats
- Confusion
- Increased Hunger
- Loss of Consciousness
- Nightmares
[Note: Various medications can lead to different side effects. For precise details about a particular drug’s specific side effects, consult the official prescribing information for that medication or seek advice from your healthcare provider.]
Ondero Met 2.5mg/850mg Tablet – A Guide to Safety

Alcohol
Unsafe
When using the Ondero Met 2.5/850 Tablet, it is important to avoid alcohol to prevent the occurrence of a dangerous condition called lactic acidosis, which involves the buildup of lactic acid in the body.
Pregnancy
Consult Your Doctor
It may not be advisable to use during pregnancy. There is limited research on humans. However, studies on animals have shown adverse effects on fetal development. Your doctor will evaluate the benefits and potential risks before prescribing it.
Breastfeeding
Unsafe
It’s probably unsafe to use while nursing. The baby could be adversely affected because the medication can pass into the breastmilk, based on the limited available information. Breastfeeding should be postponed until the mother’s treatment is finished and the drug has been removed from her body. It’s important to seek advice from your doctor.
Driving
Caution
If your blood sugar is too low or too high, it might impair your driving ability. If you experience these symptoms, refrain from driving.
Liver
Unsafe
Linagliptin and Metformin combination may not be safe for use in patients with liver disease and should be avoided. It is advisable to seek advice from your doctor.
Kidney
Caution
People with kidney issues should be cautious when using it. Adjusting the medication dosage may be necessary. Please consult your doctor. However, the Ondero Met 2.5/850 Tab is not recommended for those with severe kidney disease.
Fact Box
Chemical Group | Biguanide and Xanthines |
Addictive | No |
Medication Class | Biguanide and Dipeptidyl peptidase-4 (DPP-4) inhibitor |
Action Class/Category | Antihyperglycemic agent (Anti-Diabetic) |
Swift Advice
- Seek medical help for severe upper stomach pain, nausea, vomiting, or appetite loss—possible signs of pancreatitis.
- Take as directed, even if you skip meals; carry sugary snacks for low blood sugar symptoms like sweating or dizziness.
- Stop medication before surgeries requiring anesthesia.
- Inform your doctor of unusual thirst, frequent urination, or fatigue—may signal high blood sugar.
- Rare risk of lactic acidosis with kidney issues; watch for muscle pain, breathing trouble, or discomfort.
- Long-term use may lower vitamin B12; report fatigue, pale skin, or breathlessness to your doctor.
Does Linagliptin/Metformin affect blood pressure?
Ondero Met 2.5mg/850mg Tablet is a combination of two active substances: metformin and linagliptin. Metformin belongs to a class of medicines called biguanides, while linagliptin is a DPP-4 inhibitor. These medications work together to lower blood glucose levels, which is essential for managing diabetes. However, there is no direct effect of Ondero Met on blood pressure. It primarily focuses on controlling blood sugar levels.
Can Ondero Met 2.5mg/850mg be taken before or after meals?
The initial recommended dose of Ondero Met 2.5mg/850mg Tablet is usually one tablet taken orally once daily. It is generally advisable to take it with meals to reduce the chances of developing an upset stomach. Your doctor may adjust the dose based on your response to treatment, up to a maximum dose of 5 mg Linagliptin and 2550 mg Metformin per day.
What is the difference between Metformin and Linagliptin?
Metformin is a biguanide that primarily works by reducing glucose production in the liver and improving insulin sensitivity in peripheral tissues.
Linagliptin, on the other hand, is a DPP-4 inhibitor that enhances insulin secretion and reduces glucagon release. Both medications help lower blood glucose levels, but they have different mechanisms of action.
How often should Ondero Met 2.5mg/850mg be taken?
The usual starting dose of metformin (850 mg tablet) is once or twice daily with or after meals. Gradually, the dose can be increased if necessary to 2 to 3 grams daily.
It’s essential to follow your doctor’s instructions regarding the dosing schedule and any adjustments.
Who is the leading exporter of Ondero Met 2.5mg/850mg?
If you are interested in purchasing Ondero Met 2.5mg/850mg in bulk, contact The Lotus Biotech for the most competitive offers. We supply high-quality medications to meet all your shipping needs. Email us at info@thelotusbiotech.com to obtain customized price quotes based on your specific requirements and quantities.